Crinetics Pharmaceuticals CRNX
CRNX
$84.95 +0.00 (+0.00%)
At close: Sep 2, 2026 · 4:00 PM EDT

Crinetics Pharmaceuticals (CRNX) Long-Term Debt Repayments (2017)

Updated

Crinetics Pharmaceuticals' Long-Term Debt Repayments was $176,000 in Q4 2017.

Analysis

Crinetics Pharmaceuticals (CRNX) Long-Term Debt Repayments (2017) Analysis & Trends

For FY2017, Long-Term Debt Repayments at Crinetics Pharmaceuticals came in at $212,000, up 341.7% from FY2016.

  • In earlier years, Long-Term Debt Repayments was $48,000 in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 2.00 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 5.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -2.45 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 17.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Crinetics Pharmaceuticals 8.99 Bn 8.99 Bn 24.96 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 176,000.00
Sep 30, 2017 13,000.00
API Access

Crinetics Pharmaceuticals Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=CRNX&period=max&api_key=YOUR_API_KEY